Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Endo International PLC (NASDAQ:ENDP)

21.03
Delayed Data
As of Aug 26
 0.00 / 0.00%
Today’s Change
12.56
Today|||52-Week Range
84.57
-65.65%
Year-to-Date
Forget Mylan, Buy These 3 Drug Stocks Instead
Aug 26 / Zacks.com - Paid Partner Content
Endo (ENDP) Withdraws Label Expansion Filing for Opana ER
Aug 16 / Zacks.com - Paid Partner Content
Stock Market News for August 26, 2016
Aug 26 / Zacks.com - Paid Partner Content
Why AngloGold Ashanti, Mid-America Apartment Communities, and Endo International Slum...
Aug 15 / MotleyFool.com - Paid Partner Content
Stock Market News for August 25, 2016
Aug 25 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close21.03
Today’s open21.10
Day’s range20.75 - 21.45
Volume4,627,022
Average volume (3 months)9,276,692
Market cap$4.7B
Dividend yield--
Data as of 3:59pm ET, 08/26/2016

Growth & Valuation

Earnings growth (last year)-55.88%
Earnings growth (this year)-2.15%
Earnings growth (next 5 years)+3.50%
Revenue growth (last year)+13.61%
P/E ratioNM
Price/Sales3.69
Price/Book0.78

Competitors

 Today’s
change
Today’s
% change
TSROTESARO Inc+1.23+1.44%
OPKOPKO Health Inc+0.09+1.00%
GRFSGrifols SA-0.16-0.99%
UTHRUnited Therapeutics ...-1.50-1.22%
Data as of 3:59pm ET, 08/26/2016

Financials

Next reporting dateNovember 1, 2016
EPS forecast (this quarter)$0.85
Annual revenue (last year)$3.3B
Annual profit (last year)-$1.5B
Net profit margin-9.18%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Rajiv De Silva
SVP-Operations, Research &
Development Strategy
Robert J. Cobuzzi
Corporate headquarters
Dublin, Dublin

Forecasts

Partner Offers

Search for Jobs